Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium via its complement control protein domains 19 and 20, which also recognize heparan sulfate (HS). Abnormalities in FH are associated with the renal diseases atypical hemolytic uremic syndrome and dense deposit disease and the ocular disease age-related macular degeneration. Although FH systemically controls complement activation, clinical phenotypes selectively manifest in kidneys and eyes, suggesting the presence of tissue-specific determinants of disease development. Recent results imply the importance of tissue-specifically expressed, sulfated glycosaminoglycans (GAGs), like HS, in determining FH binding to and activity on host tissues. There...
Complement factor H (FH) systemically inhibits excessive complement activation in the microenvironme...
Complement activation at a particular location is determined by the balance of activating and inhibi...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (CFH) regulates complement activation in host tissues through its recognition of...
Complement factor H (CFH) regulates complement activation in host tissues through its recognition of...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) systemically inhibits excessive complement activation in the microenvironme...
Complement activation at a particular location is determined by the balance of activating and inhibi...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (CFH) regulates complement activation in host tissues through its recognition of...
Complement factor H (CFH) regulates complement activation in host tissues through its recognition of...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) systemically inhibits excessive complement activation in the microenvironme...
Complement activation at a particular location is determined by the balance of activating and inhibi...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...